{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:19:10Z","timestamp":1787242750282,"version":"build-2736575974"},"reference-count":128,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,12,1]]},"abstract":"<jats:title>This Technical Report was retired January 2009.<\/jats:title>\n                  <jats:p>Epidemiologic studies have shown that children of all ages with certain chronic conditions, such as asthma, and otherwise healthy children younger than 24 months (6 through 23 months) are hospitalized for influenza and its complications at high rates similar to those experienced by the elderly. Annual influenza immunization is already recommended for all children 6 months and older with high-risk conditions. By contrast, influenza immunization has not been recommended for healthy young children. To protect children against the complications of influenza, increased efforts are needed to identify and recall high-risk children. In addition, immunization of children between 6 through 23 months of age and their close contacts is now encouraged to the extent feasible. Children younger than 6 months may be protected by immunization of their household contacts and out-of-home caregivers. The ultimate goal is universal immunization of children 6 to 24 months of age. Issues that need to be addressed before institution of routine immunization of healthy young children include education of physicians and parents about the morbidity caused by influenza, adequate vaccine supply, and appropriate reimbursement of practitioners for influenza immunization. This report contains a summary of the influenza virus, protective immunity, disease burden in children, diagnosis, vaccines, and antiviral agents.<\/jats:p>","DOI":"10.1542\/peds.110.6.e80","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T20:17:55Z","timestamp":1092428275000},"page":"e80-e80","source":"Crossref","is-referenced-by-count":39,"title":["Technical Report: Reduction of the Influenza Burden in Children"],"prefix":"10.1542","volume":"110","author":[{"given":"Margaret B.","family":"Rennels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Cody","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Committee on Infectious Diseases","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2002,12,1]]},"reference":[{"key":"2023081713560243900_R1","doi-asserted-by":"crossref","unstructured":"Shaw MW, Arden NH, Maassab HF. New aspects of influenza viruses. Clin Microbiol Rev.1992;5:74\u201392","DOI":"10.1128\/CMR.5.1.74"},{"key":"2023081713560243900_R2","unstructured":"Renegar KB. Influenza virus infections and immunity: a review of human and animal models. Lab Anim Sci.1992;42:222\u2013232"},{"key":"2023081713560243900_R3","doi-asserted-by":"crossref","unstructured":"Van Reeth K, Nauwynck H, Pensaert M. Bronchoalveolar interferon-alpha, tumor necrosis factor-alpha, interleukin-1, and inflammation during acute influenza in pigs: a possible model for humans?J Infect Dis.1998;177:1076\u20131079","DOI":"10.1086\/517398"},{"key":"2023081713560243900_R4","doi-asserted-by":"crossref","unstructured":"Abramson JS, Wheeler JG. Virus-induced neutrophil dysfunction: role in the pathogenesis of bacterial infections. Pediatr Infect Dis J.1994;13:643\u2013652","DOI":"10.1097\/00006454-199407000-00012"},{"key":"2023081713560243900_R5","doi-asserted-by":"crossref","unstructured":"Renegar KB, Small PA Jr. Passive transfer of local immunity to influenza virus infection by IgA antibody. J Immunol.1991;146:1972\u20131978","DOI":"10.4049\/jimmunol.146.6.1972"},{"key":"2023081713560243900_R6","doi-asserted-by":"crossref","unstructured":"Renegar KB, Small PA Jr. Immunoglobulin A mediation of murine nasal anti-influenza virus immunity. J Virol.1991;65:2146\u20132148","DOI":"10.1128\/jvi.65.4.2146-2148.1991"},{"key":"2023081713560243900_R7","doi-asserted-by":"crossref","unstructured":"Glezen WP, Couch RB. Interpandemic influenza in the Houston area, 1974\u201376. N Engl J Med.1978;298:587\u2013592","DOI":"10.1056\/NEJM197803162981103"},{"key":"2023081713560243900_R8","doi-asserted-by":"crossref","unstructured":"Neuzil KM, Zhu Y, Griffen MR, et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis.2002;185:147\u2013152","DOI":"10.1086\/338363"},{"key":"2023081713560243900_R9","doi-asserted-by":"crossref","unstructured":"Sullivan KM, Monto AS, Longini IM Jr. Estimates of the US health impact of influenza. Am J Public Health.1993;83:1712\u20131716","DOI":"10.2105\/AJPH.83.12.1712"},{"key":"2023081713560243900_R10","doi-asserted-by":"crossref","unstructured":"Glezen WP, Decker M, Joseph SW, Mercready RG Jr. Acute respiratory disease associated with influenza epidemics in Houston, 1981\u20131983. J Infect Dis.1987;155:1119\u20131126","DOI":"10.1093\/infdis\/155.6.1119"},{"key":"2023081713560243900_R11","doi-asserted-by":"crossref","unstructured":"Heikkinen T, Thint M, Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med.1999;340;260\u2013264","DOI":"10.1056\/NEJM199901283400402"},{"key":"2023081713560243900_R12","unstructured":"Ruuskanen O, Arola M, Putto-Laurila A, et al. Acute otitis media and respiratory virus infections. Pediatr Infect Dis J.1989;8:94\u201399"},{"key":"2023081713560243900_R13","doi-asserted-by":"crossref","unstructured":"Abramson JS, Giebink GS, Quie PG. Influenza A virus-induced polymorphonuclear leukocyte dysfunction in the pathogenesis of experimental pneumococcal otitis media. Infect Immun.1982;36:289\u2013296","DOI":"10.1128\/iai.36.1.289-296.1982"},{"key":"2023081713560243900_R14","doi-asserted-by":"crossref","unstructured":"Cooper JA Jr, Carcelen R, Culbreth R. Effects of influenza A nucleoprotein on polymorphonuclear neutrophil function. J Infect Dis.1996;173:279\u2013284","DOI":"10.1093\/infdis\/173.2.279"},{"key":"2023081713560243900_R15","doi-asserted-by":"crossref","unstructured":"Fainstein V, Musher DM, Cate TR. Bacterial adherence to pharyngeal cells during viral infection. J Infect Dis.1980;141:172\u2013176","DOI":"10.1093\/infdis\/141.2.172"},{"key":"2023081713560243900_R16","doi-asserted-by":"crossref","unstructured":"Giebink GS, Wright PF. Different virulence of influenza A virus strains and susceptibility to pneumococcal otitis media in chinchillas. Infect Immun.1983;41:913\u2013920","DOI":"10.1128\/iai.41.3.913-920.1983"},{"key":"2023081713560243900_R17","unstructured":"Kleinerman ES, Daniels CA, Polisson RP, Snyderman R. Effect of virus infection on the inflammatory response. Depression of macrophage accumulation in influenza-infected mice. Am J Pathol.1976;85:373\u2013382"},{"key":"2023081713560243900_R18","doi-asserted-by":"crossref","unstructured":"Plotkowski MC, Puchelle E, Beck G, Jacquot J, Hannoun C. Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A\/PR8 virus. Am Rev Respir Dis.1986;134:1040\u20131044","DOI":"10.1164\/arrd.1986.134.5.1040"},{"key":"2023081713560243900_R19","doi-asserted-by":"crossref","unstructured":"Chonmaitree T, Owen MJ, Patel JA, Hedgpeth D, Horlick D, Howie VM. Effect of viral respiratory tract infection on outcome of acute otitis media. J Pediatr.1992;120:856\u2013862","DOI":"10.1016\/S0022-3476(05)81950-X"},{"key":"2023081713560243900_R20","doi-asserted-by":"crossref","unstructured":"Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med.2000;342:225\u2013231","DOI":"10.1056\/NEJM200001273420401"},{"key":"2023081713560243900_R21","doi-asserted-by":"crossref","unstructured":"O\u2019Brien KL, Walters MI, Sellman J, et al. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis.2000;30:784\u2013789","DOI":"10.1086\/313772"},{"key":"2023081713560243900_R22","doi-asserted-by":"crossref","unstructured":"Neuzil KM, Wright PF, Mitchel EF Jr, Griffin MR. The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr.2000;137:856\u2013864","DOI":"10.1067\/mpd.2000.110445"},{"key":"2023081713560243900_R23","doi-asserted-by":"crossref","unstructured":"Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med.2000;342:232\u2013239","DOI":"10.1056\/NEJM200001273420402"},{"key":"2023081713560243900_R24","doi-asserted-by":"crossref","unstructured":"Barker WH, Mullooly JP. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol.1980;112:798\u2013811","DOI":"10.1093\/oxfordjournals.aje.a113052"},{"key":"2023081713560243900_R25","doi-asserted-by":"crossref","unstructured":"Simonsen L, Fukuda K, Schoenberger LB, Cox NJ. The impact of influenza epidemics on hospitalizations. J Infect Dis.2000;181:831\u2013837","DOI":"10.1086\/315320"},{"key":"2023081713560243900_R26","doi-asserted-by":"crossref","unstructured":"Peltola V, Heikkinen T, Ruuskanen O. Clinical courses of croup caused by influenza and parainfluenza viruses. Pediatr Infect Dis J.2002;21:76\u201378","DOI":"10.1097\/00006454-200201000-00020"},{"key":"2023081713560243900_R27","doi-asserted-by":"crossref","unstructured":"Chiu SS, Tse CY, Lau YL, Peiris M. Influenza A infection is an important cause of febrile seizures. Pediatrics.2001;108(4). Available at: http:\/\/www.pediatrics.org\/cgi\/content\/full\/108\/4\/e63","DOI":"10.1542\/peds.108.4.e63"},{"key":"2023081713560243900_R28","doi-asserted-by":"crossref","unstructured":"Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev.1996;18:64\u201376","DOI":"10.1093\/oxfordjournals.epirev.a017917"},{"key":"2023081713560243900_R29","doi-asserted-by":"crossref","unstructured":"Glezen WP. Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev.1982;4:25\u201344","DOI":"10.1093\/oxfordjournals.epirev.a036250"},{"key":"2023081713560243900_R30","doi-asserted-by":"crossref","unstructured":"Mullooly JP, Barker WH. Impact of type A influenza on children: a retrospective study. Am J Public Health.1982;72:1008\u20131016","DOI":"10.2105\/AJPH.72.9.1008"},{"key":"2023081713560243900_R31","doi-asserted-by":"crossref","unstructured":"Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol.1998;148:1094\u20131102","DOI":"10.1093\/oxfordjournals.aje.a009587"},{"key":"2023081713560243900_R32","doi-asserted-by":"crossref","unstructured":"Ferson MJ, Morton JR, Robertson PW. Impact of influenza on morbidity in children with cystic fibrosis. J Paediatr Child Health.1991;27:308\u2013311","DOI":"10.1111\/j.1440-1754.1991.tb02545.x"},{"key":"2023081713560243900_R33","doi-asserted-by":"crossref","unstructured":"Neuzil KM, Reed GW, Mitchel EF Jr, Griffin MR. Influenza-associated morbidity and mortality in young and middle-aged women. JAMA.1999;281:901\u2013907","DOI":"10.1001\/jama.281.10.901"},{"key":"2023081713560243900_R34","doi-asserted-by":"crossref","unstructured":"Lin JC, Nichol KL. Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. Arch Intern Med.2001;161:441\u2013446","DOI":"10.1001\/archinte.161.3.441"},{"key":"2023081713560243900_R35","doi-asserted-by":"crossref","unstructured":"Togashi T, Matsuzono Y, Narita M. Epidemiology of influenza-associated encephalitis-encephalopathy in Hokkaido, the northernmost island of Japan. Pediatr Int.2000;42:192\u2013196","DOI":"10.1046\/j.1442-200x.2000.01202.x"},{"key":"2023081713560243900_R36","doi-asserted-by":"crossref","unstructured":"Okabe N, Yamashita K, Taniguchi K, Inouye S. Influenza surveillance system of Japan and acute encephalitis and encephalopathy in the influenza season. Pediatr Int.2000;42:187\u2013191","DOI":"10.1046\/j.1442-200x.2000.01206.x"},{"key":"2023081713560243900_R37","doi-asserted-by":"crossref","unstructured":"Kasai T, Togashi T, Morishima T. Encephalopathy associated with influenza epidemics. Lancet.2000;355:1558\u20131559","DOI":"10.1016\/S0140-6736(05)74614-6"},{"key":"2023081713560243900_R38","doi-asserted-by":"crossref","unstructured":"Fujimoto F, Kobayashi M, Uemura O, et al. PCR on cerebrospinal fluid to show influenza-associated acute encephalopathy or encephalitis. Lancet.1998;352:873\u2013875","DOI":"10.1016\/S0140-6736(98)12449-2"},{"key":"2023081713560243900_R39","doi-asserted-by":"crossref","unstructured":"Ito Y, Ichiyama T, Kimura H, et al. Detection of influenza virus RNA by reverse transcription-PCR and proinflammatory cytokines in influenza-virus-associated encephalopathy. J Med Virol.1999;58:420\u2013425","DOI":"10.1002\/(SICI)1096-9071(199908)58:4<420::AID-JMV16>3.0.CO;2-T"},{"key":"2023081713560243900_R40","doi-asserted-by":"crossref","unstructured":"Cox NJ, Subbarao K. Influenza. Lancet.1999;354:1277\u20131282","DOI":"10.1016\/S0140-6736(99)01241-6"},{"key":"2023081713560243900_R41","doi-asserted-by":"crossref","unstructured":"Espy MJ, Smith TF, Harmon MW, Kendal AP. Rapid detection of influenza virus by shell vial assay with monoclonal antibodies. J Clin Microbiol.1986;24:677\u2013679","DOI":"10.1128\/jcm.24.4.677-679.1986"},{"key":"2023081713560243900_R42","doi-asserted-by":"crossref","unstructured":"Stockton J, Ellis JS, Saville M, Clewley JP, Zambon MC. Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses. J Clin Microbiol.1998;36:2990\u20132995","DOI":"10.1128\/JCM.36.10.2990-2995.1998"},{"key":"2023081713560243900_R43","doi-asserted-by":"crossref","unstructured":"Bernstein DI, Zahradnik JM, DeAngelis CJ, Cherry JD. Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months. Pediatrics.1982;69:404\u2013408","DOI":"10.1542\/peds.69.4.404"},{"key":"2023081713560243900_R44","doi-asserted-by":"crossref","unstructured":"Gruber WC, Taber LH, Glezen WP, et al. Live attenuated and inactivated influenza vaccine in school-age children. Am J Dis Child.1990;144:595\u2013600","DOI":"10.1001\/archpedi.1990.02150290089035"},{"key":"2023081713560243900_R45","doi-asserted-by":"crossref","unstructured":"Gonzalez M, Pirez MC, Ward E, Dibarboure H, Garcia A, Picolet H. Safety and immunogenicity of a paediatric presentation of an influenza vaccine. Arch Dis Child.2000;83:488\u2013491","DOI":"10.1136\/adc.83.6.488"},{"key":"2023081713560243900_R46","doi-asserted-by":"crossref","unstructured":"Neuzil KM, Dupont WD, Wright PF, Edwards KM. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J.2001;20:733\u2013740","DOI":"10.1097\/00006454-200108000-00004"},{"key":"2023081713560243900_R47","doi-asserted-by":"crossref","unstructured":"Kramarz P, Destefano F, Gargiullo PM, et al. Does influenza vaccination prevent asthma exacerbations in children?J Pediatr.2001;138:306\u2013310","DOI":"10.1067\/mpd.2001.112168"},{"key":"2023081713560243900_R48","doi-asserted-by":"crossref","unstructured":"American Lung Association Asthma Research Centers. The safety of inactivated influenza vaccine in adults and children with asthma. N Engl J Med.2001;345:1529\u20131536","DOI":"10.1056\/NEJMoa011961"},{"key":"2023081713560243900_R49","doi-asserted-by":"crossref","unstructured":"Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, et al. Guillain-Barre\u0301 syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977. Am J Epidemiol.1979;110:105\u2013123","DOI":"10.1093\/oxfordjournals.aje.a112795"},{"key":"2023081713560243900_R50","doi-asserted-by":"crossref","unstructured":"Safranek TJ, Lawrence DN, Kurland LT, et al. Reassessment of the association between Guillain-Barre\u0301 syndrome and receipt of swine influenza vaccine in 1976\u20131977: results of a two-state study. Expert Neurology Group. Am J Epidemiol.1991;133:940\u2013951","DOI":"10.1093\/oxfordjournals.aje.a115973"},{"key":"2023081713560243900_R51","doi-asserted-by":"crossref","unstructured":"Hurwitz ES, Schonberger LB, Nelson DB, Holman RC. Guillain-Barre\u0301 syndrome and the 1978\u20131979 influenza vaccine. N Engl J Med.1981;304:1557\u20131561","DOI":"10.1056\/NEJM198106253042601"},{"key":"2023081713560243900_R52","doi-asserted-by":"crossref","unstructured":"Kaplan JE, Katona P, Hurwitz ES, Schonberger LB. Guillain-Barre\u0301 syndrome in the United States, 1979\u20131980 and 1980\u20131981. Lack of an association with influenza vaccination. JAMA.1982;248:698\u2013700","DOI":"10.1001\/jama.248.6.698"},{"key":"2023081713560243900_R53","unstructured":"Chen R, Kent J, Rhodes P, Simon P, Schoenberger L. Investigation of a possible association between influenza vaccination and Guillian-Barre\u0301 in the United States, 1990\u20131991 [Abstract 040]. Post-Marketing Surveillance.1992;6:5\u20136"},{"key":"2023081713560243900_R54","doi-asserted-by":"crossref","unstructured":"Lasky T, Terracciano GJ, Magder L, et al. The Guillain-Barre\u0301 syndrome and the 1992\u20131993 and 1993\u20131994 influenza vaccines. N Engl J Med.1998;339:1797\u20131802","DOI":"10.1056\/NEJM199812173392501"},{"key":"2023081713560243900_R55","doi-asserted-by":"crossref","unstructured":"Staprans SI, Hamilton BL, Follansbee SE, et al. Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med.1995;182:1727\u20131737","DOI":"10.1084\/jem.182.6.1727"},{"key":"2023081713560243900_R56","doi-asserted-by":"crossref","unstructured":"O\u2019Brien WA, Grovit-Ferbas K, Namazi A, et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood.1995;86:1082\u20131089","DOI":"10.1182\/blood.V86.3.1082.bloodjournal8631082"},{"key":"2023081713560243900_R57","doi-asserted-by":"crossref","unstructured":"Gunthard HF, Wong JK, Spina CA, et al. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy. J Infect Dis.2000;181:522\u2013531","DOI":"10.1086\/315260"},{"key":"2023081713560243900_R58","doi-asserted-by":"crossref","unstructured":"Tasker SA, O\u2019Brien WA, Treanor JJ, et al. Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial. Vaccine.1998;16:1039\u20131042","DOI":"10.1016\/S0264-410X(97)00275-2"},{"key":"2023081713560243900_R59","doi-asserted-by":"crossref","unstructured":"Glesby MJ, Hoover DR, Farzadegan H, Margolick JB, Saah AJ. The effect of influenza vaccination on human immunodeficiency virus type 1 load: a randomized, double-blind, placebo-controlled study. J Infect Dis.1996;174:1332\u20131336","DOI":"10.1093\/infdis\/174.6.1332"},{"key":"2023081713560243900_R60","doi-asserted-by":"crossref","unstructured":"Fowke KR, D\u2019Amico R, Chernoff DN, et al. Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients. AIDS.1997;11:1013\u20131021","DOI":"10.1097\/00002030-199708000-00010"},{"key":"2023081713560243900_R61","doi-asserted-by":"crossref","unstructured":"Jackson CR, Vavro CI, Valentine ME, et al. Effect of influenza immunization on immunologic and virologic characteristics of pediatric patients infected with human immunodeficiency virus. Pediatr Infect Dis J.1997;16:200\u2013204","DOI":"10.1097\/00006454-199702000-00007"},{"key":"2023081713560243900_R62","doi-asserted-by":"crossref","unstructured":"Fuller JD, Craven DE, Steger KA, Cox N, Heeren TC, Chernoff D. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response. Clin Infect Dis.1999;28:541\u2013547","DOI":"10.1086\/515170"},{"key":"2023081713560243900_R63","doi-asserted-by":"crossref","unstructured":"Sullivan PS, Hanson DL, Dworkin MS, Jones JL, Ward JW. Effect of influenza vaccination on disease progression among HIV-infected persons. AIDS.2000;14:2781\u20132785","DOI":"10.1097\/00002030-200012010-00018"},{"key":"2023081713560243900_R64","doi-asserted-by":"crossref","unstructured":"Hurwitz ES, Haber M, Chang A, et al. Studies of the 1996\u20131997 inactivated influenza vaccine among children attending day care: immunologic response, protection against infection, and clinical effectiveness. J Infect Dis.2000;182:1218\u20131221","DOI":"10.1086\/315820"},{"key":"2023081713560243900_R65","doi-asserted-by":"crossref","unstructured":"Groothuis JR, Levin MJ, Rabalais GP, Meiklejohn G, Lauer BA. Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine. Pediatrics.1991;87:823\u2013828","DOI":"10.1542\/peds.87.6.823"},{"key":"2023081713560243900_R66","doi-asserted-by":"crossref","unstructured":"Groothuis JR, Levin MJ, Lehr MV, Weston JA, Hayward AR. Immune response to split-product influenza vaccine in preterm and full-term young children. Vaccine.1992;10:221\u2013225","DOI":"10.1016\/0264-410X(92)90156-E"},{"key":"2023081713560243900_R67","doi-asserted-by":"crossref","unstructured":"Clover RD, Crawford S, Glezen WP, Taber LH, Matson CC, Couch RB. Comparison of heterotypic protection against influenza A\/Taiwan\/86 (H1N1) by attenuated and inactivated vaccines to A\/Chile\/83-like viruses. J Infect Dis.1991;163:300\u2013304","DOI":"10.1093\/infdis\/163.2.300"},{"key":"2023081713560243900_R68","unstructured":"Hoberman A, Greenberg DP, Paradise JL, et al. Efficacy of influenza vaccine in the prevention of acute otitis media [Abstract 906]. Pediatr Res.2002;51:156A"},{"key":"2023081713560243900_R69","doi-asserted-by":"crossref","unstructured":"Chadwick EG, Chang G, Decker MD, Yogev R, Dimichele D, Edwards KM. Serologic response to standard inactivated influenza vaccine in human immunogenicity virus-infected children. Pediatr Infect Dis J.1994;13:206\u2013211","DOI":"10.1097\/00006454-199403000-00008"},{"key":"2023081713560243900_R70","unstructured":"Ionita E, Gherghina I, Lupulescu E, Alexandrescu V, Tabra ME. The response in hemagglutinoinhibiting antibodies following influenza vaccination of HIV-infected children. Roum Arch Microbiol Immunol.1998;57:53\u201357"},{"key":"2023081713560243900_R71","doi-asserted-by":"crossref","unstructured":"Huang KL, Ruben FL, Rinaldo CR Jr, Kingsley L, Lyter DW, Ho M. Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. JAMA.1987;257:2047\u20132050","DOI":"10.1001\/jama.257.15.2047"},{"key":"2023081713560243900_R72","doi-asserted-by":"crossref","unstructured":"Kroon FP, van Dissel JT, de Jong JC, Zwinderman K, van Furth R. Antibody response after influenza vaccination in HIV-infected individuals: a consecutive 3-year study. Vaccine.2000;18:3040\u20133049","DOI":"10.1016\/S0264-410X(00)00079-7"},{"key":"2023081713560243900_R73","doi-asserted-by":"crossref","unstructured":"Miotti PG, Nelson KE, Dallabetta GA, Farzadegan H, Margolick J, Clements ML. The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine. JAMA.1989;262:779\u2013783","DOI":"10.1001\/jama.262.6.779"},{"key":"2023081713560243900_R74","doi-asserted-by":"crossref","unstructured":"Brown AE, Steinherz PG, Miller DR, et al. Immunization against influenza in children with cancer: results of a three-dose trial. J Infect Dis.1982;145:126","DOI":"10.1093\/infdis\/145.1.126"},{"key":"2023081713560243900_R75","doi-asserted-by":"crossref","unstructured":"Glezen WP, Glezen LS, Alcorn R. Trivalent, inactivated influenza virus vaccine in children with sickle cell disease. Am J Dis Child.1983;137:1095\u20131097","DOI":"10.1001\/archpedi.1983.02140370055018"},{"key":"2023081713560243900_R76","doi-asserted-by":"crossref","unstructured":"Heikkinen T, Ruuskanen O, Waris M, Ziegler T, Arola M, Halonen P. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child.1991;145:445\u2013448","DOI":"10.1001\/archpedi.1991.02160040103017"},{"key":"2023081713560243900_R77","unstructured":"Monto AS, Davenport FM, Napier JA, Francis T Jr. Effect of vaccination of a school-age population upon the course of an A2-Hong Kong influenza epidemic. Bull World Health Organ.1969;41:537\u2013542"},{"key":"2023081713560243900_R78","doi-asserted-by":"crossref","unstructured":"Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med.2001;344:889\u2013896","DOI":"10.1056\/NEJM200103223441204"},{"key":"2023081713560243900_R79","doi-asserted-by":"crossref","unstructured":"Clements DA, Langdon L, Bland C, Walter E. Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care. Arch Pediatr Adolesc Med.1995;149:1113\u20131117","DOI":"10.1001\/archpedi.1995.02170230067009"},{"key":"2023081713560243900_R80","doi-asserted-by":"crossref","unstructured":"Kramarz P, DeStefano F, Gargiullo PM, et al. Influenza vaccination in children with asthma in health maintenance organizations. Vaccine Safety Datalink Team. Vaccine.2000;18:2288\u20132294","DOI":"10.1016\/S0264-410X(99)00551-4"},{"key":"2023081713560243900_R81","doi-asserted-by":"crossref","unstructured":"Hall CB. Influenza: a shot or not?Pediatrics.1987;79:564\u2013566","DOI":"10.1542\/peds.79.4.564"},{"key":"2023081713560243900_R82","doi-asserted-by":"crossref","unstructured":"Poehling KA, Speroff T, Dittus RS, Griffin MR, Hickson GB, Edwards KM. Predictors of influenza virus vaccination status in hospitalized children. Pediatrics.2001;108(6). Available at: http:\/\/www.pediatrics.org\/cgi\/content\/full\/108\/6\/e99","DOI":"10.1542\/peds.108.6.e99"},{"key":"2023081713560243900_R83","unstructured":"Maassab HF, Cox NJ, Murphy BR, Kendal AP. Biological, genetic and biochemical characterization of a cold-adapted recombinant A\/Victoria\/3\/75 virus and its evaluation in volunteers. Dev Biol Stand.1977;39:25\u201331"},{"key":"2023081713560243900_R84","doi-asserted-by":"crossref","unstructured":"King JC Jr, Lagos R, Berstein DI, et al. Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children. J Infect Dis.1998;177:1394\u20131397","DOI":"10.1086\/517822"},{"key":"2023081713560243900_R85","doi-asserted-by":"crossref","unstructured":"Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N Engl J Med.1998;338:1405\u20131412","DOI":"10.1056\/NEJM199805143382002"},{"key":"2023081713560243900_R86","doi-asserted-by":"crossref","unstructured":"Belshe RB, Gruber WC, Mendelman PM, et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A\/Sydney) not contained in the vaccine. J Pediatr.2000;136:168\u2013175","DOI":"10.1016\/S0022-3476(00)70097-7"},{"key":"2023081713560243900_R87","doi-asserted-by":"crossref","unstructured":"Gaglani MJ, Piedra PA, Riggs MW, Herschler GB, Griffith ME, Glezen P. Safety of the trivalent, cold-adapted, influenza virus vaccine (CAIV-T) in a subgroup of children with history of mild intermittent wheezing\/asthma\/reactive airway disease (RAD) in a community-based, non-randomized, open-label trial. Pediatr Res.2001;49:1382. Abstract","DOI":"10.1016\/S0531-5131(01)00019-X"},{"key":"2023081713560243900_R88","doi-asserted-by":"crossref","unstructured":"Redding G, Walker RE, Hessel C, et al. Safety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J.2002;21:44\u201348","DOI":"10.1097\/00006454-200201000-00010"},{"key":"2023081713560243900_R89","doi-asserted-by":"crossref","unstructured":"Gruber WC, Campbell PW, Thompson JM, Reed GW, Roberts B, Wright PF. Comparison of live attenuated and inactivated influenza vaccines in cystic fibrosis patients and their families: results of a 3-year study. J Infect Dis.1994;169:241\u2013247","DOI":"10.1093\/infdis\/169.2.241"},{"key":"2023081713560243900_R90","doi-asserted-by":"crossref","unstructured":"King JC Jr, Fast PE, Zangwill KM, et al. Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children. Pediatr Infect Dis J.2001;20:1124\u20131131","DOI":"10.1097\/00006454-200112000-00006"},{"key":"2023081713560243900_R91","unstructured":"Wright PF, Karzon DT. Live attenuated influenza vaccines. Prog Med Virol.1987;34:70\u201388"},{"key":"2023081713560243900_R92","unstructured":"Vesikari T, Karvonen A, Korhonen I, et al. A randomized double-blind placebo-controlled trial of the safety, transmissibility and phenotypic stability of a live attenuated cold-adapted influenza virus vaccine (CAIV) in children attending day care. 40th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 17\u201320, 2000; Toronto, Ontario. Abstr 37359"},{"key":"2023081713560243900_R93","unstructured":"Wright PF, Johnson PR, Karzon DT. Clinical experience with live, attenuated vaccines in children. In: Kendal AP, Patriarca PA, eds. Options for the Control of Influenza: Proceedings of a Viratek-UCLA Symposium. New York, NY: Alan R. Liss; 1986"},{"key":"2023081713560243900_R94","doi-asserted-by":"crossref","unstructured":"Clements ML, Makhene MK, Karron RA, et al. Effective immunization with live attenuated influenza A virus can be achieved in early infancy. J Infect Dis.1996;173:44\u201351","DOI":"10.1093\/infdis\/173.1.44"},{"key":"2023081713560243900_R95","doi-asserted-by":"crossref","unstructured":"Gruber WC, Belshe RB, King JC, et al. Evaluation of live attenuated influenza vaccines in children 6\u201318 months of age: safety, immunogenicity, and efficacy. J Infect Dis.1996;173:1313\u20131319","DOI":"10.1093\/infdis\/173.6.1313"},{"key":"2023081713560243900_R96","doi-asserted-by":"crossref","unstructured":"Wright PF, Okabe N, McKee KT Jr, Maassab HF, Karzon DT. Cold-adapted recombinant influenza A virus vaccines in seronegative young children. J Infect Dis.1982;146:71\u201379","DOI":"10.1093\/infdis\/146.1.71"},{"key":"2023081713560243900_R97","doi-asserted-by":"crossref","unstructured":"Edwards KM, King JC, Steinhoff MC, et al. Safety and immunogenicity of live attenuated cold-adapted influenza B\/Ann Arbor\/1\/86 reassortant virus vaccine in infants and children. J Infect Dis.1991;163:740\u2013745","DOI":"10.1093\/infdis\/163.4.740"},{"key":"2023081713560243900_R98","doi-asserted-by":"crossref","unstructured":"Belshe R. A review of attenuation of influenza viruses by genetic manipulation. Am J Respir Crit Care Med.1995;152(4, pt 2):S72\u2013S75","DOI":"10.1164\/ajrccm\/152.4_Pt_2.S72"},{"key":"2023081713560243900_R99","unstructured":"Maassab HF, Herlocher ML, Bryant ML. Live influenza virus vaccine. In: Plotkin SA, Orienstein WA, eds. Vaccines. 3rd ed. Philadelphia, PA: WB Saunders Co; 1999:909\u2013927"},{"key":"2023081713560243900_R100","doi-asserted-by":"crossref","unstructured":"Cha TA, Kao K, Zhao J, Fast PE, Mendelman PM, Arvin A. Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial. J Clin Microbiol.2000;38:839\u2013845","DOI":"10.1128\/JCM.38.2.839-845.2000"},{"key":"2023081713560243900_R101","doi-asserted-by":"crossref","unstructured":"Murphy BR, Nelson DL, Wright PF, Tierney EL, Phelan MA, Chanock RM. Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines. Infect Immun.1982;36:1102\u20131108","DOI":"10.1128\/iai.36.3.1102-1108.1982"},{"key":"2023081713560243900_R102","doi-asserted-by":"crossref","unstructured":"Clements ML, Betts RF, Tierney EL, Murphy BR. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J Clin Microbiol.1986;24:157\u2013160","DOI":"10.1128\/jcm.24.1.157-160.1986"},{"key":"2023081713560243900_R103","doi-asserted-by":"crossref","unstructured":"Johnson PR, Feldman S, Thompson JM, Mahoney JD, Wright PF. Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J Infect Dis.1986;154:121\u2013127","DOI":"10.1093\/infdis\/154.1.121"},{"key":"2023081713560243900_R104","doi-asserted-by":"crossref","unstructured":"Gruber WC, Darden PM, Still JG, Lohr J, Reed G, Wright PF. Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response. Vaccine.1997;15:1379\u20131384","DOI":"10.1016\/S0264-410X(97)00032-7"},{"key":"2023081713560243900_R105","doi-asserted-by":"crossref","unstructured":"Edwards KM, Dupont WD, Westrich MK, Plummer WD Jr, Palmer PS, Wright PF. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis.1994;169:68\u201376","DOI":"10.1093\/infdis\/169.1.68"},{"key":"2023081713560243900_R106","unstructured":"Piedra PA, Glezen WP. Influenza in children: epidemiology, immunity, and vaccines. Semin Pediatr Infect Dis.1991;2:140\u2013146"},{"key":"2023081713560243900_R107","doi-asserted-by":"crossref","unstructured":"Swierkosz EM, Newman FK, Anderson EL, Nugent SL, Mills GB, Belshe RB. Multidose, live attenuated, cold-recombinant, trivalent influenza vaccine in infants and young children. J Infect Dis.1994;169:1121\u20131124","DOI":"10.1093\/infdis\/169.5.1121"},{"key":"2023081713560243900_R108","doi-asserted-by":"crossref","unstructured":"Gruber WC, Kirschner K, Tollefson S, et al. Comparison of monovalent and trivalent live attenuated influenza vaccines in young children. J Infect Dis.1993;168:53\u201360","DOI":"10.1093\/infdis\/168.1.53"},{"key":"2023081713560243900_R109","doi-asserted-by":"crossref","unstructured":"Feldman S, Wright PF, Webster RG, et al. Use of influenza A virus vaccines in seronegative children: live cold-adapted versus inactivated whole virus. J Infect Dis.1985;152:1212\u20131218","DOI":"10.1093\/infdis\/152.6.1212"},{"key":"2023081713560243900_R110","doi-asserted-by":"crossref","unstructured":"Belshe RB, Van Voris LP, Bartram J, Crookshanks FK. Live attenuated influenza A virus vaccines in children: results of a field trial. J Infect Dis.1984;150:834\u2013840","DOI":"10.1093\/infdis\/150.6.834"},{"key":"2023081713560243900_R111","doi-asserted-by":"crossref","unstructured":"Belshe RB, Gruber WC, Mendelman PM, et al. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine. J Infect Dis.2000;181:1133\u20131137","DOI":"10.1086\/315323"},{"key":"2023081713560243900_R112","doi-asserted-by":"crossref","unstructured":"White T, Lavoie S, Nettleman MD. Potential cost savings attributable to influenza vaccination of school-aged children. Pediatrics.1999;103(6). Available at: http:\/\/www.pediatrics.org\/cgi\/content\/full\/103\/6\/e73","DOI":"10.1542\/peds.103.6.e73"},{"key":"2023081713560243900_R113","doi-asserted-by":"crossref","unstructured":"Cohen GM, Nettleman MD. Economic impact of influenza vaccination in preschool children. Pediatrics.2000;106:973\u2013976","DOI":"10.1542\/peds.106.5.973"},{"key":"2023081713560243900_R114","doi-asserted-by":"crossref","unstructured":"Luce BR, Zangwill KM, Palmer CS, et al. Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children. Pediatrics.2001;108(2). Available at: http:\/\/www.pediatrics.org\/cgi\/content\/full\/108\/2\/e24","DOI":"10.1542\/peds.108.2.e24"},{"key":"2023081713560243900_R115","doi-asserted-by":"crossref","unstructured":"Riddiough MA, Sisk JE, Bell JC. Influenza vaccination. JAMA.1983;249:3189\u20133195","DOI":"10.1001\/jama.249.23.3189"},{"key":"2023081713560243900_R116","doi-asserted-by":"crossref","unstructured":"Meltzer MI, Cox NJ, Fukuda K. The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg Infect Dis.1999;5:659\u2013671","DOI":"10.3201\/eid0505.990507"},{"key":"2023081713560243900_R117","doi-asserted-by":"crossref","unstructured":"Couch RB. Prevention and treatment of influenza. N Engl J Med.2000;343:1778\u20131787","DOI":"10.1056\/NEJM200012143432407"},{"key":"2023081713560243900_R118","doi-asserted-by":"crossref","unstructured":"Pinto LH, Holsinger LJ, Lamb RA. Influenza virus M2 protein has ion channel activity. Cell.1992;69:517\u2013528","DOI":"10.1016\/0092-8674(92)90452-I"},{"key":"2023081713560243900_R119","unstructured":"Bridges CB, Fukuda K, Cox NJ, Singleton JA. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep.2001;50(RR-4):1\u201344"},{"key":"2023081713560243900_R120","doi-asserted-by":"crossref","unstructured":"Crawford SA, Clover RD, Abell TD, Ramsey CN Jr, Glezen P, Couch RB. Rimantadine prophylaxis in children: a follow-up study. Pediatr Infect Dis J.1988;7:379\u2013383","DOI":"10.1097\/00006454-198806000-00002"},{"key":"2023081713560243900_R121","doi-asserted-by":"crossref","unstructured":"Clover RD, Waner JL, Becker L, Davis A. Effect of rimantadine on the immune response to influenza A infections. J Med Virol.1991;34:68\u201373","DOI":"10.1002\/jmv.1890340112"},{"key":"2023081713560243900_R122","unstructured":"Centers for Disease Control and Prevention. Neuraminidase inhibitors for treatment of influenza A and B infections. MMWR Recomm Rep.1999;48(RR-14):1\u20139"},{"key":"2023081713560243900_R123","doi-asserted-by":"crossref","unstructured":"Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors. Lancet.2000;355:827\u2013835","DOI":"10.1016\/S0140-6736(99)11433-8"},{"key":"2023081713560243900_R124","doi-asserted-by":"crossref","unstructured":"Hedrick JA, Barzilai A, Behre U, et al. Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial. Pediatr Infect Dis J.2000;19:410\u2013417","DOI":"10.1097\/00006454-200005000-00005"},{"key":"2023081713560243900_R125","doi-asserted-by":"crossref","unstructured":"Whitley RJ, Hayden FG, Reisinger KS, et al. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J.2001;20:127\u2013133","DOI":"10.1097\/00006454-200102000-00002"},{"key":"2023081713560243900_R126","doi-asserted-by":"crossref","unstructured":"Welliver R, Monto AS, Carewicz O, et al. Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial. JAMA.2001;285:748\u2013754","DOI":"10.1001\/jama.285.6.748"},{"key":"2023081713560243900_R127","doi-asserted-by":"crossref","unstructured":"Hayden FG, Gubareva LV, Monto AS, et al. Inhaled zanamivir for the prevention of influenza in families. N Engl J Med.2000;343:1282\u20131289","DOI":"10.1056\/NEJM200011023431801"},{"key":"2023081713560243900_R128","unstructured":"US Preventive Services Task Force. Ratings. Guide to Clinical Preventive Services. Washington, DC: US Department of Health and Human Services; 1996:862"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/110\/6\/e80\/1519638\/pe12020000u1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/110\/6\/e80\/1519638\/pe12020000u1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T09:56:43Z","timestamp":1692266203000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/110\/6\/e80\/64534\/Technical-Report-Reduction-of-the-Influenza-Burden"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12,1]]},"references-count":128,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2002,12,1]]},"published-print":{"date-parts":[[2002,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.110.6.e80","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12,1]]}}}